Yan J - Search Results

1

The role of third complement component (C3) in homing of hematopoietic stem/progenitor cells into bone marrow.

Reca R, Wysoczynski M, Yan J, Lambris JD, Ratajczak MZ. Reca R, et al. Among authors: yan j. Adv Exp Med Biol. 2006;586:35-51. doi: 10.1007/0-387-34134-X_3. Adv Exp Med Biol. 2006. PMID: 16893063 Review. No abstract available.

2

Therapeutic intervention with complement and beta-glucan in cancer.

Ross GD, Vetvicka V, Yan J, Xia Y, Vetvicková J. Ross GD, et al. Among authors: yan j. Immunopharmacology. 1999 May;42(1-3):61-74. doi: 10.1016/s0162-3109(99)00013-2. Immunopharmacology. 1999. PMID: 10408367 Review.

3

Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).

Yan J, Vetvicka V, Xia Y, Coxon A, Carroll MC, Mayadas TN, Ross GD. Yan J, et al. J Immunol. 1999 Sep 15;163(6):3045-52. J Immunol. 1999. PMID: 10477568

4

Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble beta-glucan.

Yan J, Vetvicka V, Xia Y, Hanikýrová M, Mayadas TN, Ross GD. Yan J, et al. Immunopharmacology. 2000 Jan;46(1):39-54. doi: 10.1016/s0162-3109(99)00157-5. Immunopharmacology. 2000. PMID: 10665778

5

Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models.

Hong F, Yan J, Baran JT, Allendorf DJ, Hansen RD, Ostroff GR, Xing PX, Cheung NK, Ross GD. Hong F, et al. Among authors: yan j. J Immunol. 2004 Jul 15;173(2):797-806. doi: 10.4049/jimmunol.173.2.797. J Immunol. 2004. PMID: 15240666

6

C5a-mediated leukotriene B4-amplified neutrophil chemotaxis is essential in tumor immunotherapy facilitated by anti-tumor monoclonal antibody and beta-glucan.

Allendorf DJ, Yan J, Ross GD, Hansen RD, Baran JT, Subbarao K, Wang L, Haribabu B. Allendorf DJ, et al. Among authors: yan j. J Immunol. 2005 Jun 1;174(11):7050-6. doi: 10.4049/jimmunol.174.11.7050. J Immunol. 2005. PMID: 15905548

7

Beta-glucan enhances complement-mediated hematopoietic recovery after bone marrow injury.

Cramer DE, Allendorf DJ, Baran JT, Hansen R, Marroquin J, Li B, Ratajczak J, Ratajczak MZ, Yan J. Cramer DE, et al. Among authors: yan j. Blood. 2006 Jan 15;107(2):835-40. doi: 10.1182/blood-2005-07-2705. Epub 2005 Sep 22. Blood. 2006. PMID: 16179370 Free PMC article.

8

Toll-like receptor engagement stimulates anti-snRNP autoreactive B cells for activation.

Ding C, Wang L, Al-Ghawi H, Marroquin J, Mamula M, Yan J. Ding C, et al. Among authors: yan j. Eur J Immunol. 2006 Aug;36(8):2013-24. doi: 10.1002/eji.200635850. Eur J Immunol. 2006. PMID: 16810634

9

Yeast beta-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathway.

Li B, Allendorf DJ, Hansen R, Marroquin J, Ding C, Cramer DE, Yan J. Li B, et al. Among authors: yan j. J Immunol. 2006 Aug 1;177(3):1661-9. doi: 10.4049/jimmunol.177.3.1661. J Immunol. 2006. PMID: 16849475

10

Modulation of the SDF-1-CXCR4 axis by the third complement component (C3)--implications for trafficking of CXCR4+ stem cells.

Ratajczak MZ, Reca R, Wysoczynski M, Yan J, Ratajczak J. Ratajczak MZ, et al. Among authors: yan j. Exp Hematol. 2006 Aug;34(8):986-95. doi: 10.1016/j.exphem.2006.03.015. Exp Hematol. 2006. PMID: 16863905 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results